바로가기메뉴

본문 바로가기 주메뉴 바로가기

logo

Case of Effective Treatment using Glucagon-Like Peptide-1 Receptor Agonist in Patient with Obesity and Non-Alcoholic Fatty Liver Disease

Archives of Obesity and Metabolism / Archives of Obesity and Metabolism, (P)2951-0333; (E)2951-0597
2023, v.2 no.2, pp.71-75
https://doi.org/10.23137/AOM23.02.CR0004
Tae Sic Lee (Department of Family Medicine, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea)
  • Downloaded
  • Viewed

Abstract

Obesity is closely related to chronic diseases and cancer. The present case report aims to discuss the anti-obesity treatment strategy and the evaluation of the clinical progress in a patient with obesity and concurrent fatty liver disease. Following five months of treatment with liraglutide and rosuvastatin, the patient had a weight reduction of 3 kg (4.7%), a decrease in fasting blood sugar by 42 mg/dl (26.6%), a decrease in low-density lipoprotein cholesterol by 82 mg/dl (60.2%), and decrease in alanine transaminase. This case report documented the treatment of a patient with common chronic diseases encountered in the outpatient setting. Based on the therapeutic effects documented in clinical and laboratory indices, the anti-obesity treatment plan significantly aided in managing chronic diseases.

keywords
Liraglutide, Statin, Non-alcoholic fatty liver disease, Dyslipidemia

Archives of Obesity and Metabolism